MEGAN SCHOLLENBERGER: Open Payments
NPI 1952643116 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$424 in 9 payments from 8 companies in 2025. Trend: 2023 $675 · 2024 $103 · 2025 $424
Food & beverage: $424
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 1 | $122 |
| Regeneron Pharmaceuticals, Inc. | 1 | $116 |
| AstraZeneca Pharmaceuticals LP | 2 | $73 |
| Janssen Biotech, Inc. | 1 | $34 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| Janssen Scientific Affairs, LLC | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $19 |
Products named: OPDIVO, LIBTAYO, TECVAYLI, KISQALI, KEYTRUDA.
Industry payments across MD — which companies pay providers there.
